Management of Heavy Prolonged Menstrual Bleeding with Marked Anemia
This patient requires immediate multidisciplinary evaluation with concurrent acute bleeding control, aggressive anemia correction, and investigation for underlying bleeding disorders—bleeding lasting two months is a medical emergency requiring urgent intervention.
Immediate Acute Management
Start high-dose hormonal therapy immediately to control the prolonged bleeding 1. For acute bleeding control, you have several evidence-based options:
- Combined oral contraceptives: 3-4 times daily until bleeding stops (typically 24-48 hours), then taper over 7-10 days 2
- High-dose progestins: Norethisterone 5mg three times daily until bleeding stops 3
- Tranexamic acid: 1-1.5g three times daily (can be combined with hormonal therapy) 1, 4
For marked anemia, assess hemoglobin level immediately 1. If hemoglobin is severely low (<7 g/dL) or the patient is hemodynamically unstable, consider packed red blood cell transfusion 5, 3. Otherwise, initiate aggressive iron replacement.
Iron Replacement Strategy
Iron deficiency with or without anemia must be treated regardless of hemoglobin level 1. The approach depends on severity:
- Intravenous iron is preferred for severe anemia, failed oral therapy, or when rapid correction is needed before potential surgery 5, 6, 7
- Oral iron (if chosen): 100-200mg elemental iron on alternate days for better absorption and tolerance 5
- Monitor hemoglobin and ferritin at baseline and reassess response 8, 4
Given the two-month duration of bleeding, this patient likely has severe iron depletion requiring IV iron rather than oral supplementation 7, 8.
Critical Diagnostic Evaluation
Screen for underlying bleeding disorders immediately—up to 33% of adolescents and 10% of adults with heavy menstrual bleeding have an inherited bleeding disorder, most commonly von Willebrand disease or platelet function disorders 9, 8. This is particularly critical given the extreme duration of bleeding.
Essential workup includes:
- Complete blood count with platelet count
- Ferritin level (target >20 ng/mL for adequate iron stores) 5
- Coagulation studies: PT, aPTT, fibrinogen
- von Willebrand factor antigen, activity, and factor VIII levels
- Thyroid function tests and prolactin 1
- Pregnancy test (beta-hCG)
- Pelvic ultrasound to exclude structural causes 10, 11
Refer to multidisciplinary hematology-gynecology clinic for comprehensive evaluation 9, 12, 9. These specialized clinics significantly improve outcomes by coordinating bleeding disorder diagnosis, menstrual management, and long-term care planning.
Bridging and Long-Term Management
After acute control, implement bridging therapy to prevent recurrence while planning definitive management 3:
- Continuous progestin therapy: Norethisterone 5mg daily or depot medroxyprogesterone acetate injection 3, 13
- Continuous combined hormonal contraceptives (if no contraindications) 3
- Tranexamic acid during any breakthrough bleeding 4, 3
For long-term maintenance, the levonorgestrel-releasing intrauterine system (LNG-IUS) provides the most effective bleeding reduction (93% reduction at 6 months) with highest compliance 13. However, insertion should be delayed until bleeding is controlled and anemia is corrected 3.
Common Pitfalls to Avoid
Do not delay treatment waiting for complete diagnostic workup—start acute bleeding control immediately while investigations proceed 12.
Do not assume this is "just heavy periods"—two months of continuous bleeding is pathologic and requires urgent investigation for bleeding disorders, structural lesions, or endometrial pathology 9.
Do not use oral iron alone in severe anemia—IV iron provides faster correction and avoids the 1-2 year delays to adequate treatment commonly seen with oral-only approaches 7, 8.
Do not forget to assess impact on quality of life, physical activity, and psychosocial functioning—these patients often have severe functional impairment requiring comprehensive support 1, 14.
Monitoring and Follow-up
Reassess PBAC score (Pictorial Blood Loss Assessment Chart), hemoglobin, and ferritin at 3 and 6 months 8, 13. If first-line therapy fails, escalate to second-line options or consider surgical intervention (endometrial ablation or hysterectomy) for patients not desiring future fertility 10, 11.